|
|
skeletal system development
|
GO:0001501 |
356 |
0.163
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.137
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.125
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.123
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.122
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.117
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.117
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.113
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.100
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.085
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.072
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.071
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.068
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.068
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.067
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.066
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.066
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.063
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.059
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.058
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.057
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.057
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.057
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.056
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.056
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.056
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.056
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.055
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.054
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.053
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.053
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.053
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.053
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.052
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.052
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.050
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.049
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.048
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.047
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.047
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.047
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.047
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.046
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.046
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.046
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.046
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.046
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.045
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.045
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.045
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.045
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.044
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.043
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.043
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.043
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.043
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.042
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.041
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.041
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.041
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.041
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.040
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.040
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.039
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.038
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.038
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.038
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.038
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.038
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.038
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.037
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.037
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.037
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.037
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.037
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.037
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.036
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.036
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.036
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.036
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.035
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.035
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.035
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.035
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.035
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.034
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.034
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.034
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.034
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.034
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.034
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.033
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.033
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.033
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.033
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.032
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.032
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.032
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.032
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.032
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.031
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.031
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.031
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.031
|
|
|
|
renal capsule specification
|
GO:0072130 |
1 |
0.031
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.031
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.031
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.031
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.031
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.030
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.030
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.030
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.030
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.030
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.030
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.030
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.030
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.030
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.029
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.029
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.029
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.029
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.029
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.029
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.029
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.029
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.029
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.029
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.029
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.029
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.029
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.029
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.029
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.029
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.028
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.028
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.028
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.028
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.028
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.028
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.028
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.028
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.028
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.027
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.027
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.027
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.026
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.026
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.026
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.026
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.025
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.025
|
|
|
|
biological phase
|
GO:0044848 |
20 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.025
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.025
|
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.025
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.025
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.025
|
|
|
|
menarche
|
GO:0042696 |
1 |
0.025
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.025
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.025
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.025
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.024
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.024
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.024
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.024
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.024
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.024
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.024
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.024
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.024
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.024
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.024
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.024
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.023
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.023
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.023
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.023
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.023
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.023
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.023
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.023
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.023
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.023
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.023
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.023
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.023
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.023
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.023
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.023
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.023
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.023
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.023
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.022
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.022
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.022
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.022
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.022
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.022
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.022
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.022
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.022
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.022
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.022
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.022
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.022
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.022
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.022
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.022
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.022
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.022
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.021
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.021
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.021
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.021
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.021
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.021
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.021
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.021
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.021
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.021
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.021
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.021
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.021
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.021
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.020
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.020
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.020
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.020
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.020
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.020
|
|
|
|
granulosa cell differentiation
|
GO:0060014 |
1 |
0.020
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.020
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.020
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.020
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.020
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.020
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.020
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.020
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.020
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.020
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.020
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.020
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.020
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.020
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.020
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.019
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.019
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.019
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.019
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.019
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.019
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.019
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.019
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.019
|
|
|
|
epithelial cell proliferation involved in prostatic bud elongation
|
GO:0060517 |
1 |
0.019
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.019
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.019
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.019
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.019
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.019
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.018
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.018
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.018
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.018
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.018
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.018
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.018
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.018
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.018
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.018
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.018
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.018
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.018
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.018
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.018
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.018
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.018
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.018
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.018
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.018
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.018
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.018
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.017
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.017
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.017
|
|
|
|
germ line sex determination
|
GO:0018992 |
3 |
0.017
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.017
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.017
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.017
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.017
|
|
|
|
ventral spinal cord interneuron specification
|
GO:0021521 |
11 |
0.017
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.017
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.017
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.017
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.017
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.017
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.017
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.017
|
|
|
|
positive regulation of cell migration involved in sprouting angiogenesis
|
GO:0090050 |
3 |
0.017
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.017
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.017
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.017
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.017
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.017
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.017
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.016
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.016
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.016
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.016
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.016
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.016
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.016
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.016
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.016
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.016
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.016
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.016
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.016
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.016
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.016
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.016
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.016
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.016
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.016
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.016
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.016
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.016
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.016
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.016
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.016
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.016
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.016
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.016
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.016
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.016
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.016
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.016
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.016
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.016
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.015
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.015
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.015
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.015
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.015
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.015
|
|
|
|
female somatic sex determination
|
GO:0019101 |
1 |
0.015
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.015
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.015
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.015
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.015
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.015
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.015
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.015
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.015
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.015
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.015
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.015
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.015
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.015
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.015
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.015
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.015
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.015
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.014
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.014
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.014
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.014
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.014
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.014
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.014
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.014
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.014
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.014
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.014
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.014
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.014
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.014
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.014
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.014
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.014
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.014
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.014
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.014
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.014
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.014
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.014
|
|
|
|
negative regulation of transcription by glucose
|
GO:0045014 |
1 |
0.014
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.014
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.014
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.014
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.014
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.014
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.014
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.014
|
|
|
|
metanephric capsule formation
|
GO:0072266 |
1 |
0.014
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.013
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.013
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.013
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.013
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.013
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.013
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.013
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.013
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.013
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.013
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.013
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.013
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.013
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.013
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.013
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.013
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.013
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.013
|
|
|
|
negative regulation of chondrocyte differentiation
|
GO:0032331 |
13 |
0.013
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.013
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.013
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.013
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.013
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.013
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.013
|
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.013
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.013
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.013
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.013
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.013
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.013
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.013
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.013
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.013
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.013
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.013
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.013
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.013
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.013
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.013
|
|
